Meridian Bioscience Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.1M
Doctors Paid
705
Transactions
1,500
2024 Total
$439,423
Payment Breakdown by Category
Research$1.3M (63.2%)
Consulting$83,047 (4.0%)
Food & Beverage$17,689 (0.8%)
Travel$521.94 (0.0%)
Royalty/License$225.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 90 | 63.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $632,590 | 450 | 30.3% |
| Consulting Fee | $83,047 | 43 | 4.0% |
| Food and Beverage | $17,689 | 895 | 0.8% |
| Grant | $11,500 | 9 | 0.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,750 | 8 | 0.5% |
| Education | $6,250 | 2 | 0.3% |
| Charitable Contribution | $5,000 | 1 | 0.2% |
| Travel and Lodging | $521.94 | 1 | 0.0% |
| Royalty or License | $225.00 | 1 | 0.0% |
Payments by Type
Research
$1.3M
90 transactions
General
$767,573
1,410 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Illumigene CMV Clinical Trial Protocol | $181,084 | 0 | 10 |
| Illumigene MV Clinical Trial Protocol | $124,387 | 0 | 5 |
| Evaluating prelimary performance and setting assay cut-offs for the Revogene SMART RP assay | $103,054 | 0 | 9 |
| Premier HpSA Ultra Clinical Trial Protocol | $73,902 | 0 | 4 |
| Capillary blood study with LeadCare II Protocol | $67,407 | 0 | 5 |
| Curian HpSA Clinical Trial Protocol | $66,411 | 0 | 3 |
| Curian C. difficile Clinial Trial | $60,465 | 0 | 14 |
| Curian Shiga Toxin Clinial Trial | $55,283 | 0 | 2 |
| Curian Campy Clinical Trial | $54,838 | 0 | 3 |
| Cytomegalovirus Research Stage, Pre-Clinical Study Protocol- Specimen Collection | $50,818 | 0 | 8 |
| Curian C. difficile Clinical Trial | $41,418 | 0 | 3 |
| Clinical evaluation of the molecular-based Revogene Enteric Panel Assay | $38,564 | 0 | 4 |
| Illumigene CMV Research Agreement | $30,286 | 0 | 3 |
| Evaluating prelimary performance and setting assay cut-offs for the Revogene Enteric Panel Assay | $24,440 | 0 | 2 |
| Illumigene Group A Strep Product Study | $15,765 | 0 | 1 |
| HpSA Sample Type Comparability Study | $12,120 | 0 | 2 |
| Illumigene Group A Strep Studies | $11,900 | 0 | 1 |
| Illumigene CMV Study | $11,250 | 0 | 2 |
| IC STAT! Campy and IC STAT! EHEC Clinical Trial | $9,600 | 0 | 2 |
| Curian Cdiff Alpha Study | $9,190 | 0 | 1 |
| FLU, RSV MTA | $6,500 | 0 | 2 |
| Premier HpSA Ultra Clinical Trial | $4,800 | 0 | 1 |
| Helicobacter pylori Research Stage, Pre-Clinical Study Protocol- Specimen Collection | $200.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Ellen Moreland, Acns, ACNS | Adult Health | Glenwood, AR | $57.35 | $0 |
| David Kim, Md, MD | Anesthesiology | Englewood, NJ | $56.48 | $0 |
| Dr. Brian Rabinowitz, Md, MD | Pediatrics | Hicksville, NY | $56.18 | $0 |
| Dr. David Schwartz, M.d, M.D | Adolescent Medicine | Bartlett, IL | $55.82 | $0 |
| Michael Kagen, M.d, M.D | Internal Medicine | Park City, UT | $54.34 | $0 |
| Dr. Jay Begun, M.d, M.D | Pediatrics | Brooklyn, NY | $52.14 | $0 |
| Dr. Walther Pfeifer, M.d, M.D | Anatomic Pathology & Clinical Pathology | Boston, MA | $50.81 | $0 |
| Alejandro Perez-Trepichio, Md, MD | Internal Medicine | Naples, FL | $50.16 | $0 |
| Stephanie Carlucci, M.d, M.D | Pediatrics | North Bellmore, NY | $50.11 | $0 |
| Lena Edelstein, M.d, M.D | Student in an Organized Health Care Education/Training Program | Plainview, NY | $48.62 | $0 |
| Dr. Naomi Zilkha, Md, MD | Pediatrics | Plainview, NY | $48.33 | $0 |
| Dr. David King, Md, MD | Anatomic Pathology & Clinical Pathology | Irving, TX | $46.74 | $0 |
| Rajeev Nagpal, Md, MD | Pediatric Gastroenterology | Oak Lawn, IL | $46.34 | $0 |
| Dr. Jessika Wagner, Md, MD | Pediatrics | Ogden, UT | $46.34 | $0 |
| Peter Silas, M.d, M.D | Pediatrics | Syracuse, UT | $46.33 | $0 |
| Dr. Daniel Stampfl, Md, MD | Pediatrics | Draper, UT | $46.33 | $0 |
| Scott Hansen, Md, MD | Specialist | Provo, UT | $46.10 | $0 |
| Kathleen Langer, Md, MD | Obstetrics & Gynecology | Bluffdale, UT | $46.10 | $0 |
| Dr. Janet Eddy, M.d, M.D | Obstetrics & Gynecology | Riverton, UT | $46.10 | $0 |
| Kimberly Moreland, Md, MD | Specialist | Santa Cruz, CA | $46.10 | $0 |
| Dr. Leon Schwechter, D.o, D.O | Internal Medicine | Greenvale, NY | $45.69 | $0 |
| Dr. Ana Dellorusso, Md, MD | Pediatrics | Floral Park, NY | $43.71 | $0 |
| Dr. Melissa Cascio-Leva, M.d, M.D | Pediatrics | Floral Park, NY | $43.71 | $0 |
| Dr. Karen Rubel, Md, MD | Pediatrics | Great Neck, NY | $43.30 | $0 |
| Heidi Russ, M.d, M.D | Pediatrics | Great Neck, NY | $43.30 | $0 |
Ad
Top Products
- Illumigene CMV $407,015
- Revogene $166,059
Associated Products (13)
- Illumigene CMV $407,015
- Revogene $166,059
- HPSA $133,987
- C diff $101,883
- Shiga Toxin $77,816
- Leadcare II $67,407
- Campy $54,838
- Premier Platinum HpSA $49,690
- Immunocard Stat Ehec $28,479
- Illumigene GAS $28,267
- Curian Cdiff $18,720
- Illumigene Cdiff $12,769
- Immunocard STAT! HPSA $12,221
Payment Categories
- Food & Beverage $17,689
- Consulting $83,047
- Travel & Lodging $521.94
- Research $1.3M
- Royalties $225.00
About Meridian Bioscience Inc.
Meridian Bioscience Inc. has made $2.1M in payments to 705 healthcare providers, recorded across 1,500 transactions in the CMS Open Payments database. In 2024, the company paid $439,423. The top product by payment volume is Illumigene CMV ($407,015).
Payments were distributed across 62 medical specialties. The top specialty by payment amount is Gastroenterology ($60,108 to 84 doctors).
Payment categories include: Food & Beverage ($17,689), Consulting ($83,047), Research ($1.3M), Travel & Lodging ($521.94), Royalties ($225.00).
Meridian Bioscience Inc. is associated with 13 products in the CMS Open Payments database, including Illumigene CMV, Revogene, and HPSA.